About the Swedish-American Life Science Summit
The Swedish-American Life Science Summit 2009 is the fifth in a series
of summits, an invitation-only format where we present a program featuring
some of the best known Life Science executives and investors in the
The intense and exclusive two-day program includes high-level panel discussions, insights from keynote speakers as well as a few selected presentations by successful and promising Swedish companies.
It is our hope and ambition that the summit will serve to increase the amount of cross-border business between the largest market in the world, the United States, and one of the most important Life Science industry centers in Europe, Sweden.
The people behind the Swedish-American Life Science Summit combine a long experience in the US pharmaceutical industry and Wall Street with today’s financial services within the field of Life Science in both countries.
Barbro Ehnbom was one of the first female executives in the US pharmaceutical industry, and a top analyst in Wall Street, followed by many years of investment banking. As a long time board member of the Swedish-American Chamber of Commerce and Chairman Emeritus of the Swedish Economist Group in New York, she has 25 years experience in organizing events between the two countries.
View Curriculum Vitae »
View article from Dagens Industri (pdf, 90Kb) »
Official Advisor :
Frederick Frank is Vice Chairman of Peter J. Solomon Company. Mr. Frank brings to the summit over forty-five years of experience. Before joining Peter J. Solomon Company Mr. Frank was Vice Chairman of Lehman Brothers and Barclays Capital. Prior to joining Lehman Brothers he was Director of research and a Director of Smith, Barney & Co. Inc. He serves on the Board of Directors of several public companies and has provided investment banking services to an extensive number of companies in the pharmaceutical, biotechnology, healthcare service providers, medical device and nutraceutical industries, and has been involved in hundreds of financings and merger and acquisition transactions in the global health care industry.
View article from Biotech Sweden (hi-res jpg, 2Mb) »
View article from Dagens Industri »
Mathias Uhlén is Professor of Microbiology at the Royal Institute of Technology (KTH), Stockholm, Sweden. Dr. Uhlén is member of the Royal Swedish Academy of Engineering Science (IVA), the Royal Swedish Academy of Science (KVA) and the European Molecular Biology Organization (EMBO). He is Vice-President of the European Proteomics Association (EuPA) and member of the Human Proteome Organization (HUPO) council. Dr Uhlén has more than 290 publications in bioscience with the focus on the development and use of affinity reagents in biotechnology and biomedicine.
Staff, organizing committee:
Claudia Olsson is a Master student in Industrial Engineering and Management at the Royal Institute of Technology and in International Economics at the Stockholm School of Economics. Claudia has studied in Germany and France and has worked for the Swedish Trade Council in Warsaw and for the United Nations Headquarters in New York. Prior to joining the Swedish-American Life Science Summit Claudia managed the Stockholm International Youth Science Seminar in connection with the Nobel Foundation.
Erika Morén is a recently graduated Master student in Industrial Engineering and Management from the Royal Institute of Technology Stockholm, Sweden. Ms Morén studied and worked both in both Australia and the United States. She is a member of the female network BBB, headed by Ms Barbro Ehnbom.
Cecilia Schött is a Master student in Industrial Engineering and Management at the Royal Institute of Technology (KTH). She is a member of the female network BBB, headed by Ms Barbro Ehnbom and has previously also worked with the Female Economist of the Year scholarship at Stockholm School of Economics.